Align Technology - ALGN Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 1 sell rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ALGN shares.
View ALGN analyst ratings or view top-rated stocks.

8 Wall Street research analysts have issued 1-year price targets for Align Technology's shares. Their ALGN share price forecasts range from $165.00 to $418.00. On average, they expect the company's stock price to reach $300.78 in the next twelve months. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for ALGN or view top-rated stocks among Wall Street analysts.

Align Technology's stock was trading at $210.90 on January 1st, 2023. Since then, ALGN stock has increased by 34.0% and is now trading at $282.53.
View the best growth stocks for 2023 here.

Align Technology saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 2,300,000 shares, an increase of 31.4% from the December 31st total of 1,750,000 shares. Based on an average trading volume of 1,100,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately 3.1% of the shares of the stock are sold short.
View Align Technology's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our ALGN earnings forecast.

Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings data on Tuesday, October, 26th. The medical equipment provider reported $2.87 earnings per share for the quarter, beating analysts' consensus estimates of $2.60 by $0.27. The medical equipment provider earned $1.02 billion during the quarter, compared to analyst estimates of $977.81 million. Align Technology had a net margin of 13.22% and a trailing twelve-month return on equity of 14.39%. The company's revenue for the quarter was up 38.4% on a year-over-year basis. During the same period last year, the business posted $1.76 EPS.
Read the conference call transcript.

Align Technology updated its first quarter 2023 earnings guidance on Wednesday, February, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $901.51 million-$901.51 million, compared to the consensus revenue estimate of $889.51 million.

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology's stock is owned by many different retail and institutional investors. Top institutional investors include Parnassus Investments LLC (0.60%), Keybank National Association OH (0.55%), Riverbridge Partners LLC (0.32%), Sumitomo Mitsui Trust Holdings Inc. (0.27%), Allspring Global Investments Holdings LLC (0.25%) and Scout Investments Inc. (0.21%). Insiders that own company stock include Andrea Lynn Saia, C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Kevin C Burns, Robert E Fitzgerald, Simon Beard, Stuart A Hockridge, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends.

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALGN stock can currently be purchased for approximately $282.53.

Align Technology (NASDAQ:ALGN) has a market capitalization of $22.07 billion and generates $3.86 billion in revenue each year. The medical equipment provider earns $772.02 million in net income (profit) each year or $6.47 on an earnings per share basis.

The company employs 22,540 workers across the globe.

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for the company is www.aligntech.com. The medical equipment provider can be reached via phone at (408) 470-1000, via email at align@ethoscommunication.com, or via fax at 408-470-1010.